Monday 19th February 2024

(2 months, 1 week ago)

Westminster Hall
Read Full debate Read Hansard Text Read Debate Ministerial Extracts

Westminster Hall is an alternative Chamber for MPs to hold debates, named after the adjoining Westminster Hall.

Each debate is chaired by an MP from the Panel of Chairs, rather than the Speaker or Deputy Speaker. A Government Minister will give the final speech, and no votes may be called on the debate topic.

This information is provided by Parallel Parliament and does not comprise part of the offical record

Elliot Colburn Portrait Elliot Colburn
- Hansard - - - Excerpts

I absolutely agree with my right hon. Friend. This is something that we cannot stress enough in this debate: it has been proven in the data time and again that non-animal methods are highly accurate, and much more accurate when it comes to predicting human responses than animal testing is. In fact, animal testing has such low levels of success when it comes to measuring how a drug or something else might affect a human that we would not accept that in any other form of business. When the levels of prediction are so poor, why are we still accepting it? It does not make any sense—not when we have alternatives that can offer much greater clarity about to how humans will react to products and drugs.

However, there are challenges standing in the way, and one of them remains funding for NAMs. Pfizer and AstraZeneca have said that they do not want to do things such as secondary species testing, but regulatory guidelines often expect new drugs to be tested on animals and there is a lack of consensus on possible transition timelines. There is also push-back from the industry, which is resistant to change. However, in advance of this debate I spoke to many scientists and industry leads who said they are crying out for change and want to be at the forefront of non-animal methods. We need to give them the tools to do so and look at the way we fund research.

Lisa Cameron Portrait Dr Lisa Cameron (East Kilbride, Strathaven and Lesmahagow) (Con)
- Hansard - -

My hon. Friend is making a fantastic speech. He is standing up for all the animals that do not have a voice in the industry and speaking for those across the UK who want to support them. Several organisations contacted me and talked about the need for change. They said that we must look after animals—particularly beagle pups—post testing where possible, but they pointed out that the industry has been very resistant to engaging with rehoming centres, even when the beagle pups have not undergone lethal testing. Surely we can do better. Whenever an animal can have a life in a loving home afterwards, we must make that happen.

Elliot Colburn Portrait Elliot Colburn
- Hansard - - - Excerpts

My hon. Friend is absolutely right, and I hope the Minister heard that.

Commercial breeding—in particular, of beagles—is hard for this country to accept. The data shows that a lot of such testing, if not all of it, is unnecessary because the accuracy of the tests is so low. Given that secondary species tests on dogs seem so unnecessary, why are we still allowing them to happen?

Since the debate last year, there has been some welcome news internationally: Canada, Australia and countries within the European Union have come up with road maps for ending animal testing. It is critical that we ask the Government to consider how we do that. We need a strategy and a road map to work with the industry, campaign groups, charities, other organisations and the people who are in the Public Gallery today, to move us away from the use of animals and towards non-animal methods as the default standard. I appreciate that some countries have found it difficult to come up with precise timelines because of disagreements within the sector, but that does not mean we should not try. That is the key thing to take away from this debate.

There are things that we can do in the immediate and interim terms, one of which is to look at animal welfare standards. Twenty-three people looking at 3 million procedures simply is not enough. We also need an immediate review of the necessity of secondary species testing. Whatever happens next, it is imperative that we prioritise the development and adoption of non-animal research methods. The fact the number of scientific procedures conducted on animals went up in 2021—we actually stopped collecting data after that point, so we are not entirely sure how many we are doing, which I think is a mistake—demonstrates that there is not enough impetus behind the agenda of moving towards non-animal methods.

I ask the Government to invest in and fund NAMs properly by reallocating existing funds and promoting collaboration. They have an incredible ability to bring together the industry, researchers, advocacy groups, campaigners and others to create a road map and a strategy so we can truly say that the UK does not need to use animal testing methods any more. We can stop the use of animals and hold ourselves up to an incredibly high international standard as a nation of animal lovers.